Related Experiment Video
Updated: Jan 22, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma
Tao Peng1, Xiang Deng1, Feng Tian1
1Hepatobiliary Surgery Institute, Southwest Hospital, Army Medical University, Chongqing 400038, P.R. China.
Abstract:
Cholangiocarcinoma (CCA) is the second most common hepatobiliary cancer after hepatocellular carcinoma. Antiangiogenic therapy has been administered to patients with CCA, but the benefits of this therapy remain unsatisfactory. Improved understanding of the molecular mechanisms underlying angiogenesis in CCA is required. In the present study, the expression of GATA‑binding protein 6 (GATA6), lysyl oxidase‑like 2 (LOXL2) and vascular endothelial growth factor A (VEGFA), in addition to the microvessel density (MVD), were evaluated by performing immunohistochemical staining of human CCA microarrays. The expression of GATA6/LOXL2 was associated with poor overall survival (P=0.01) and disease‑free survival (P=0.02), and was positively associated with VEGFA expression (P=0.02) and MVD (P=0.04). In vitro, western blotting, reverse transcription‑quantitative PCR analysis and ELISAs revealed that altered GATA6 and LOXL2 expression regulated the expression levels of secreted VEGFA. Co‑immunoprecipitation demonstrated a physical interaction between GATA6 and LOXL2 in CCA cell lines, and the scavenger receptor cysteine‑rich domain of LOXL2 interacted with GATA6, which regulated VEGFA mRNA expression and protein secretion, and promoted tube formation. In vivo analyses further revealed that GATA6/LOXL2 promoted VEGFA expression, angiogenesis and tumor growth. The GATA6/LOXL2 complex represents a novel candidate prognostic marker for stratifying patients with CCA. Drugs targeting this complex may possess great therapeutic value in the treatment of CCA.
Insights
The GATA6/LOXL2 complex promotes cholangiocarcinoma (CCA) growth by increasing vascular endothelial growth factor A (VEGFA) and angiogenesis. Targeting this complex may offer new therapeutic strategies for CCA patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cholangiocarcinoma (CCA) is a prevalent hepatobiliary cancer with limited treatment options.
- Current antiangiogenic therapies for CCA show unsatisfactory outcomes, necessitating a deeper understanding of angiogenesis mechanisms.
- Identifying novel molecular targets is crucial for improving CCA treatment efficacy.
Purpose of the Study:
- To investigate the roles of GATA-binding protein 6 (GATA6), lysyl oxidase-like 2 (LOXL2), and vascular endothelial growth factor A (VEGFA) in CCA angiogenesis.
- To evaluate the prognostic significance of GATA6 and LOXL2 expression in CCA patients.
- To elucidate the molecular interactions between GATA6, LOXL2, and VEGFA in CCA progression.
Main Methods:
- Immunohistochemical staining of human CCA microarrays to assess GATA6, LOXL2, VEGFA expression, and microvessel density (MVD).
- In vitro experiments including western blotting, RT-qPCR, and ELISAs to analyze VEGFA regulation by GATA6 and LOXL2.
- Co-immunoprecipitation assays to confirm the physical interaction between GATA6 and LOXL2 and identify interacting domains.
Main Results:
- GATA6/LOXL2 expression correlated with poor overall and disease-free survival in CCA patients.
- GATA6/LOXL2 expression was positively associated with VEGFA levels and MVD.
- GATA6 and LOXL2 physically interact, regulating VEGFA mRNA and protein secretion, promoting angiogenesis and tumor growth in vitro and in vivo.
Conclusions:
- The GATA6/LOXL2 complex is a significant driver of angiogenesis and tumor growth in CCA.
- This complex serves as a novel prognostic marker for stratifying CCA patients.
- Targeting the GATA6/LOXL2 complex presents a promising therapeutic strategy for CCA treatment.
Related Concept Videos
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Van der Waals Interactions
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
piRNA - Piwi-interacting RNAs
Predator-Prey Interactions

